Literature DB >> 11848689

Low brain histamine content affects ethanol-induced motor impairment.

Minnamaija Lintunen1, Kristiina Raatesalmi, Tina Sallmen, Oleg Anichtchik, Kaj Karlstedt, Jan Kaslin, Kalervo Kiianmaa, Esa R Korpi, Pertti Panula.   

Abstract

The effect of ethanol on motor performance in humans is well established but how neural mechanisms are affected by ethanol action remains largely unknown. To investigate whether the brain histaminergic system is important in it, we used a genetic model consisting of rat lines selectively outbred for differential ethanol sensitivity. Ethanol-sensitive rats had lower levels of brain histamine and lower densities of histamine-immunoreactive fibers than ethanol-insensitive rats, although both rat lines showed no changes in histamine synthesizing neurons. Lowering the high brain histamine content of the ethanol-insensitive rats with alpha-fluoromethylhistidine before ethanol administration increased their ethanol sensitivity in a behavioral motor function test. Higher H3 receptor ligand binding and histamine-induced G-protein activation was detected in several brain regions of ethanol-naive ethanol-sensitive rats. Brain histamine levels and possibly signaling via H3 receptors may thus correlate with genetic differences in ethanol-induced motor impairment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11848689     DOI: 10.1006/nbdi.2001.0453

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  8 in total

1.  Ethanol inhibits histaminergic neurons in mouse tuberomammillary nucleus slices via potentiating GABAergic transmission onto the neurons at both pre- and postsynaptic sites.

Authors:  Yu Sun; Shi-Yu Jiang; Jian Ni; Yan-Jia Luo; Chang-Rui Chen; Zong-Yuan Hong; Yuchio Yanagawa; Wei-Min Qu; Lu Wang; Zhi-Li Huang
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

2.  Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice.

Authors:  Saara Nuutinen; Minnamaija Lintunen; Jenni Vanhanen; Tiia Ojala; Stanislav Rozov; Pertti Panula
Journal:  Neuropsychopharmacology       Date:  2011-06-08       Impact factor: 7.853

3.  JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats.

Authors:  Ruggero Galici; Amir H Rezvani; Leah Aluisio; Brian Lord; Edward D Levin; Ian Fraser; Jamin Boggs; Natalie Welty; James R Shoblock; S Timothy Motley; Michael A Letavic; Nicholas I Carruthers; Christine Dugovic; Timothy W Lovenberg; Pascal Bonaventure
Journal:  Psychopharmacology (Berl)       Date:  2010-11-18       Impact factor: 4.530

4.  Influence of the novel histamine H₃ receptor antagonist ST1283 on voluntary alcohol consumption and ethanol-induced place preference in mice.

Authors:  Amine Bahi; Bassem Sadek; Stephan J Schwed; Miriam Walter; Holger Stark
Journal:  Psychopharmacology (Berl)       Date:  2013-03-09       Impact factor: 4.530

5.  Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice.

Authors:  Saara Nuutinen; Kaj Karlstedt; Teemu Aitta-Aho; Esa R Korpi; Pertti Panula
Journal:  Psychopharmacology (Berl)       Date:  2009-11-13       Impact factor: 4.530

6.  Histamine h3 receptor: a novel therapeutic target in alcohol dependence?

Authors:  Saara Nuutinen; Jenni Vanhanen; Tiia Mäki; Pertti Panula
Journal:  Front Syst Neurosci       Date:  2012-05-18

7.  Acute ethanol treatment upregulates Th1, Th2, and Hdc in larval zebrafish in stable networks.

Authors:  Henri A J Puttonen; Maria Sundvik; Stanislav Rozov; Yu-Chia Chen; Pertti Panula
Journal:  Front Neural Circuits       Date:  2013-05-31       Impact factor: 3.492

8.  Estrogenic regulation of histamine receptor subtype H1 expression in the ventromedial nucleus of the hypothalamus in female rats.

Authors:  Hiroko Mori; Ken-Ichi Matsuda; Masanaga Yamawaki; Mitsuhiro Kawata
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.